News

FDA Approves Riabni Biosimilar: Expanding NHL Treatment Options

FDA · Oncology · 4 min

FDA Approval Adagrasib: Accelerated OK for KRAS G12C NSCLC Treatment

FDA · non-small cell lung cancer · 4 min

FDA Approves Apretude: First Injectable PrEP for HIV Prevention

FDA · HIV prevention · 4 min

FDA Approves Skin-Renew: New Indication for Severe Eczema

FDA · Dermatology · 7 min

FDA Updates Diabetes Therapy Label: Key Safety Warning Changes

FDA · Diabetes Mellitus · 7 min

FDA Approves GenoPharm's Geno-Cure for Targeted Cancer Treatment

FDA · Oncology · 7 min

FDA Approves AllerClear OTC: What You Need to Know

FDA · Allergic Rhinitis · 4 min

FDA Approves Bact-Away: Novel Antibiotic Against Resistant Infections

FDA · Infectious Diseases · 7 min

FDA Approves AI-Driven Drug ALGO-1 for Treatment-Resistant Depression

FDA · Treatment-Resistant Depression · 9 min

FDA Approves Semaglutide Trial Update for Obesity Treatment

FDA · obesity · 5 min

Revolution Medicines Presents Updated Zoldonrasib Phase 1 Data for KRAS G12D Lung Cancer at AACR 2026

2 min

EpiBiologics Begins Phase 1 Trial of EPI-326 Bispecific Antibody for EGFR-Driven Cancers

2 min